The Problem
Medication for opioid use disorder (MOUD) saves lives, yet thousands of Americans never complete treatment. A 2023 national study in the Journal of Drug Issues analyzed 188 000 outpatient MOUD episodes and found that individuals experiencing homelessness were significantly less likely to complete or remain in care.
Why It Matters
The findings underscore that homelessness is not just a background variable, it’s an independent predictor of treatment failure. Even when clinics offer MOUD, social determinants of health (SODH), housing instability, poverty, lack of insurance, and recent justice involvement, erode continuity. Understanding this relationship can help clinicians and policymakers design systems that retain rather than lose the most vulnerable.
Key Takeaways
- Homelessness was present in 8.7 % of treatment episodes and linked to significantly lower completion and retention.
- Unemployment, no income, and uninsurance co-occurred with homelessness, magnifying risk.
- Clinical solutions alone are insufficient, structural support (housing, insurance, transportation) must be integrated.
- Low-threshold and mobile care models can offset barriers.
- Addressing SODH is a public-health imperative, not a luxury.
Beyond the Mic
Behind every statistic is a person juggling addiction, trauma, and instability. When our systems fail to retain them, it isn’t a clinical failure, it is a failure of infrastructure and empathy. Integrating housing support into addiction care is not mission creep; it’s evidence-based medicine.
Featured Resources
- Tsai et al. (2023). A National Study of Homelessness … MOUD Engagement. J Drug Issues. DOI: 10.1177/08897077231167291
- Homelessness Programs and Resources
- National Health Care for the Homeless Council toolkit
→ Listen to the full episode on The Transformed Minds FULL EPISODE
Stay ready. Stay aware. Stay grounded.
